Drugs.com - Pharma Industry News

AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications

TUESDAY, March 11, 2025 -- Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at the annual meeting of the American...

Mar 11, 2025 - 18:23
 0
AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications
TUESDAY, March 11, 2025 -- Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at the annual meeting of the American...
Read More

Tags:

Previous Article

USPSTF: Evidence Lacking to Recommend Food Insecurity Screening

Next Article

Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment

Related Posts

Weight Loss After Antiobesity Medication Initiation Lowers Joint Revision Risk

Weight Loss After Antiobesity Medication Initiation Low...

Feb 27, 2025  0

Continuous Glucose Monitors Overestimate Glycemic Responses

Continuous Glucose Monitors Overestimate Glycemic Respo...

Mar 7, 2025  0

Study Identifies Some Modifiable Risk Factors for Ovarian Cancer

Study Identifies Some Modifiable Risk Factors for Ovari...

Feb 11, 2025  0